Ethopharmacological analysis of rat behavior on the elevated plus-maze

Adamec, 1993, Lasting effects on rodent anxiety of a single exposure to a cat, Physiol. Behav., 54, 101, 10.1016/0031-9384(93)90050-P

Almeida, 1991, Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics, Psychopharmacology, 103, 513, 10.1007/BF02244251

Archer, 1973, Tests for emotionality in rats and mice: A review, Anim. Behav., 21, 205, 10.1016/S0003-3472(73)80065-X

Audi, 1991, Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin, Psychopharmacology, 105, 553, 10.1007/BF02244379

Blanchard, 1990, Diazepam changes risk assessment in an anxiety/defense test battery, Psychopharmacology, 101, 511, 10.1007/BF02244230

Blanchard, 1989

Briley, 1990, Effects of serotonergic lesions on “anxious” behavior measured in the elevated plus-maze in the rat, Psychopharmacology, 101, 187, 10.1007/BF02244124

Chopin, 1987, Animal models of anxiety: The effect of compounds that modify 5-HT neurotransmission, Trends Pharmacol. Sci., 8, 383, 10.1016/0165-6147(87)90101-5

Critchley, 1992, Actions and some interactions of 5-HT1a ligands in the elevated X-maze and effects of dorsal raphe lesions, Psychopharmacology, 106, 484, 10.1007/BF02244819

Dorow, 1983, Severe anxiety induced by FG 7142, a β-carboline for benzodiazepine receptors, Lancet, 9, 98, 10.1016/S0140-6736(83)90076-4

File, 1992, Behavioural detection of anxiolytic action, 25

Guimarães, 1991, Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey, Psychopharmacology, 103, 91, 10.1007/BF02244080

Handley, 1993, 5-HT drugs in animal models of anxiety, Psychopharmacology, 112, 13, 10.1007/BF02247358

Handley, 1984, Effects of alpha-adrenoceptor agonists in a maze-exploration model of “fear”-motivated behaviour, Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 1, 10.1007/BF00504983

Kostowski, 1989, Intra-hippocampal buspirone in animal models of anxiety, Eur. J. Pharmacol., 186, 393, 10.1016/0014-2999(89)90803-0

Ljungberg, T.; Lidfors, L.; Enquist, M.; Ungerstedt, U. Impairment of decision making in rats by diazepam: Implications for the “anticonflict” effects of benzodiazepines. Psychopharmacology 92:416–423.

Montgomery, 1955, The relationship between fear induced by novel stimulation and exploratory behaviour, J. Comp. Physiol. Psychol., 48, 254, 10.1037/h0043788

Moser, 1989, An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone, Psychopharmacology, 99, 48, 10.1007/BF00634451

Pellow, 1986, tiAnxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat, Pharmacol. Biochem. Behav., 24, 525, 10.1016/0091-3057(86)90552-6

Pellow, 1985, Validation of open: Closed arm entries in the elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Meth., 14, 149, 10.1016/0165-0270(85)90031-7

Rodgers, 1993, Anxiety enhancement in the elevated plus-maze by immediate prior exposure to social stressors, Physiol. Behav., 53, 383, 10.1016/0031-9384(93)90222-2

Rodgers, 1992, Anxiogenic-like effects of fluprazine and eltoprazine in the elevated plus-maze; Profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP, Behav. Pharmacol., 3, 621, 10.1097/00008877-199212000-00009

Rodin, 1970, Metrazol tolerance in a ‘normal’ volunteer population, J. Nerv. Ment. Dis., 150, 438, 10.1097/00005053-197006000-00003

Russo, 1993, Role of benzodiazepine receptors located in the dorsal periaqueductal grey in anxiety, Psychopharmacology, 110, 198, 10.1007/BF02246973

Thiébot, 1991, Waiting capacity in animals. A behavioral component crossing nosologic boundaries of anxiety and depression?, 48

Trullas, 1991, Are glutamatergic pathways involved in the pathophysiology of anxiety?, 382

Treit, 1993, Anxiogenic stimuli in the elevated plus-maze, Pharmacol. Biochem. Behav., 44, 463, 10.1016/0091-3057(93)90492-C

Zorumski, 1991, Insights into the structure and function of GABA-benzodiazepine receptors: Ion channels and psychiatry, Am. J. Psychiat., 148, 162